Brain Res Bull. 2003 Aug 15;61(3):347-55
Sellebjerg F, Sorensen TL.
Department of Neurology, The MS Clinic, University of Copenhagen, Glostrup Hospital, DK-2600, Glostrup, Denmark
Chemokines and matrix metalloproteinases (MMPs) play key roles in leukocyte migration across the blood-brain barrier (BBB) in infectious and inflammatory diseases, including multiple sclerosis (MS).
In MS some chemokine receptors are expressed by an increased percentage of T cells in blood, the CSF concentration of chemokine ligands for these receptors is increased, and there is accumulation of T cells expressing relevant chemokine receptors in CSF and in the CNS parenchyma.
Chemokine receptor expression patterns appear to reflect disease activity and disease stage in MS.
MMPs are constitutively expressed or induced by proinflammatory cytokines and chemokines in leukocytes and CNS-resident cells.
Several MMPs are expressed in MS plaques, and the CSF concentration of MMP-9 is increased in MS.
The CSF concentration of MMP-9 may reflect disease activity in MS, and the CSF concentration of MMP-9 is higher in patients carrying the MS-associated HLA type DRB1(*)1501.
We review how chemokines and MMP-9 may be involved in the pathogenesis of MS by controlling leukocyte migration between different functional compartments.
Measuring expression of these molecules may find use as surrogate markers of disease activity in MS, and interfering with their function holds promise as a novel therapeutic strategy in MS.